-
-
[1]Cosenzi A.Enrasentan, an antagonist of endothelin receptors[J].Cardiovasc Drug Rev, 2003, 21 (1) ∶1-16. [2]Hocher B, Kalk P, Slowinski T, et al.ETAreceptor blockade in-duces tubular cell proliferation and cyst growth in rats with polycystickidney disease[J].J Am Soc Nephrol, 2003, 14 (2) ∶367-376. [3]Moridaira K, Morrissey J, Fitzgerald M, et al.ACE inhibition in-creases expression of the ETBreceptor in kidneys of mice with unilat-eral obstruction[J].Am J Physiol Renal Physiol, 2003, 284 (1) ∶F209-217. [4]Tieche S, De Gottardi A, Kappeler A, et al.Over expression of en-dothelin-1 in bile duct ligated rats:correlation with activation of he-patic stellate cells and portal pressure[J].J Hepatol, 2001, 34 (1) ∶38-45. [5]Uhlmann D, Armann B, Gaebel G, et al.Endothelin A receptorblockade reduces hepatic ischemia/reperfusion injury after warm is-chemia in a pig model[J].J Gastrointest Surg, 2003, 7 (3) ∶331-339. [6]Ikura Y, Ohsawa M, Naruko T, et al.Expression of the hepatic en-dothelin system in human cirrhotic livers[J].J Pathol, 2004, 204 (3) ∶304-310. [7]夏金荣.肝星状细胞与肝纤维化[J].临床荟萃, 2006, 21 (4) ∶298. [8]Yang C, Zeisheng M, Mosterman B, et al.Iiver fibrosis:insights intomigration of hepatic stellate cells in response to extracellular matrixand growth factors[J].Gastroenterology, 2003, 124 (1) ∶147-159. [9]Reeves HL, Friedman SL.Activation of hepatic stellate cells-a keyissue in liver fibrosis[J].Front Biosci, 2002, 7∶d808-d826. [10]Masahiko K, Michael B, Anja K, et al.Endothelin-1 enhancesfibrogenic gene expression, but does not promote DNA synthesis orapoptosis in hepatic stellate cells[J].Comparative Hepatology, 2006, 5∶5. [11]Watanabe N, Takashimizu S, Nishizaki Y, et al.An endothelin Are-ceptor antagonist induces dilatation of sinusoidal endothelial fenes-trae:implications for endothelin-1 in hepatic microcirculation[J].J Gastroenterol, 2007, 42 (9) ∶775-782. [12]Shibamoto T, Kamikado C, Koyama S.Increased sinusoidal resist-ance is responsible for the basal state and endothelin-induced veno-constriction in perfused cirrhotic rat liver[J].Pflugers Arch, 2008, 456 (3) ∶467-477. [13]Ghandhi CR, Stephenson K, Olson MS.Endothelin, a potent pep-tide agonist in the liver[J].J Biol Chem, 1990, 265 (29) ∶17432-17435. [14]Kuroda N, Yamanaka J, Okada T, et al.Hepatic effects of influxedendothelin-1 from portal vein:in situ portal vein infusion model u-sing dogs[J].J Hepatobiliary Pancreat Surg, 2006, 13 (2) ∶160-166. [15]王启之, 郑玉宝, 吴炎, 等.一氧化氮及内皮素在肝硬化患者肝损害中的作用及对肝门脉血流动力学的影响[J].蚌埠医学院学报, 2007, 32 (1) ∶7-9. [16]Nagasue N, Dhar DK, Yamanoi A, et al.Production and release ofendothelin-1from the gut and spleen in portal hypertension due tocirrhosis[J].J Hepatology, 2000, 31 (5) ∶1107-1114. [17]Tran Duc AT, Schwab AJ, Simard A, et al.Reduction in hepaticendothelin-1clearance in cirrhosis[J].Clin Sci, 2003, 105 (2) ∶227-234. [18]Cai L, Wang GJ, Mukherjee K, et al.Endothelins and their re-ceptors in cirrhotic and neoplastic livers of Canadian and Chinesepopulations[J].Anticancer Res, 1999, 19 (3B) ∶2243-2247. [19]Fukui R, Nishimori H, Hata F, et al.Inhibitory effect of endothe-lin A receptor blockade on tumor growth and liver metastasis of a hu-man gastric cancer cell line[J].Gastric Cancer, 2007, 10 (2) ∶123-8.
本文二维码
计量
- 文章访问数: 3152
- HTML全文浏览量: 4
- PDF下载量: 1113
- 被引次数: 0